Could a popular Weight-Loss drug also help people drink less?
NCT ID NCT06546384
Summary
This study is testing if a medication called semaglutide, which is already used for weight loss and diabetes, can help people with obesity and fatty liver disease drink less alcohol or stop drinking altogether. Over 16 weeks, researchers will compare people who receive the drug plus counseling to those who receive only counseling. The main goal is to see if the medication leads to more people achieving complete abstinence from alcohol.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Bern
Bern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.